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1 
Abstract 
A number of conditions can present with lesions that histologically are indistinguishable 
from the central giant cell granuloma (CGCG) of bone, including brown tumors of 
hyperparathyroidism, cherubism, and, less commonly, a number of inherited syndromes.  
We report a case of an eight-year girl who presented with bilateral CGCGs of the 
posterior mandible. Characteristic facial features, reported increased post-operative bleeding 
and history of pulmonary stenosis led us to suspect a diagnosis of Noonan syndrome.  A 
medical geneticist confirmed this on further evaluation.  
This case report will discuss the salient features of this diagnosis. 
2 
Case Presentation 
An eight-year-old girl (Fig. 1) was referred for evaluation after routine panoramic 
radiographic evaluation revealed well-defined bilateral multilocular radiolucencies of the 
posterior mandible associated with the developing third molars (Fig. 2).  Each lesion measured 
more than 2.5 cm in greatest dimension. Also noted was displacement of the prematurely 
developing right and left mandibular third molar teeth.  On axial computed tomographic 
examination, no cortical expansion was evident (Fig. 3). There was no history of prior trauma 
or surgery to the mandible.   
The patient was the product of a full-term uncomplicated pregnancy.  At 10 days of age 
an atrial septal defect and pulmonic stenosis were detected.  Her family history was 
unremarkable, with no record of jaw abnormalities or atypical facies among other family 
members. 
On physical examination she was at the 5th percentile for weight, 10% for height and 
50th percentile for head circumference.  She had thick kinky hair and several pigmented nevi.  
She had brilliant blue eyes with slight ptosis of the left eye.  The palpebral fissures were not 
downslanting.  Her ears were low set and small with thickened helices bilaterally (Fig.1).  The 
nose had a bulbous tip.  Pectus excavatum was present. Her neck was not webbed. A systolic 
murmur was present at the right upper sternal border.  The rest of her extra-oral examination 
was unremarkable, and no facial asymmetry or bony expansion was noted.   
A clinical and radiographic differential diagnosis was formulated (Table 1), and after 
excluding a vascular process via needle aspiration, incisional biopsies of the radiolucent 
lesions were performed. The patient’s mother reported “prolonged bleeding” during the 
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immediate post-operative period. However, it was not significant enough to require additional 
intervention. 
Discussion 
Histopathologic examination of both lesions (Fig. 4) revealed a proliferation of giant 
cells in a fibrovascular connective tissue background, consistent with a giant cell granuloma.  
Based on the histopathology, the differential diagnosis was revised to include only lesions 
with a histology compatible with CGCG, as shown in Table 2.  
Central giant cell granuloma (CGCG) is a benign lesion of bone of variably aggressive 
nature that was first described by Jaffe1. As defined by the World Health Organization, CGCG 
is a central lesion of bone with aggregates of multinucleated giant cells in a background of 
cellular fibrous connective tissue that contains multiple foci of hemorrhage with or without 
trabeculae of reactive bone.  
Initially termed “giant cell reparative granuloma”, these lesions are no longer believed to 
represent a reparative process2. Various hypotheses have been proposed to explain their 
pathogenesis, including the possibility that these are related to intraosseous hemorrhage 
following trauma, develop in association with other pre-existing bone lesions (e.g. fibrous 
dysplasia), are of neoplastic nature or represent an idiopathic reactive process. 
The peak incidence of CGCG is in the second decade, with most cases appearing 
between the ages of 10 and 25 years. It is more common in females. The radiographic 
appearance of CGCG is not pathognomonic. Usually, a radiolucent lesion, which can be either 
unilocular (usually lesions less than 6 cm) or multilocular, is noted on routine radiographic 
examination.  The borders are generally well defined. While it is frequently reported that 
lesions of CGCGs are usually located anterior to the mandibular first molar and often cross the 
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midline3, a recent review of 80 cases suggested that there is an equal predilection for the 
posterior mandible4. CGCGs can displace teeth and developing tooth follicles, but rarely cause 
tooth resorption. 
Most reported cases of multiple concurrent CGCGs are associated with some form of 
congenital syndrome or systemic disease, hence the possibility that these radiolucent lesions 
simply represented bilateral central giant cell granulomas was considered unlikely.  
 
“Brown tumors” of hyperparathyroidism are the result of excessive parathyroid 
hormone secretion. This can occur either primarily, due to hyperplasia or neoplasia of the 
parathyroid glands, or secondarily in association with renal osteodystrophy5. Hypercalcemia, 
hypophosphatemia and elevated parathyroid hormone blood levels characterize 
hyperparathyroidism. Radiographic findings are also characteristic. Besides multiple lytic 
lesions of bone, intraorally there is a loss of the lamina dura adjacent to the roots of the teeth 
and an altered trabecular pattern in the tooth bearing areas of the jaws. In our patient, an 
endocrine workup was unremarkable, effectively excluding this condition. 
 
Cherubism, an autosomal dominantly inherited condition with variable expressivity, is 
characterized by multiquadrant radiolucent lesions of the jaws.  
Clinically, cherubism is first noted between ages 1 and 4 years and is more common in 
males.  There is usually a family history of similarly affected family members. It most 
commonly manifests as a progressive and symmetrical enlargement of the mandible and/or 
the maxilla. Mandibular swelling produces plump cheeks and maxillary enlargement causes 
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retraction of the lower eyelids and elevation of the pupils upward, resulting in an “angel-like” 
appearance reminiscent of the cherubs depicted in Renaissance art.  
Dental findings include marked displacement of developing second and third molars as 
well as premature exfoliation of primary teeth. Marked cervical lymphadenopathy is common. 
Regression is often seen following puberty6. Currently cherubism is believed to be caused by a 
gain-of-function mutation in the gene coding a c-Abl-tyrosine kinase-binding protein 
(SH3BP2) located on the short arm of chromosome 47. 
A number of congenital syndromes have been reported to be associated with giant cell 
lesions of the jaws, including Noonan syndrome8, neurofibromatosis type-19 and Ramon 
syndrome (gingival fibromatosis, hypertrichosis, epilepsy, mental and somatic retardation and 
cherubism-like lesions)10.  “Noonan-like syndrome, cherubism, and polyarticular pigmented 
villonodular synovitis” is a congenital syndrome that includes additional findings of multiple 
lesions of pigmented villonodular synovitis affecting multiple bones, commonly the knees and 
ankles. 
It has been suggested8 that some of these entities represent different levels of expression 
of a contiguous gene syndrome, resulting from defects or deletions of two or more genes that 
map near each other on the same region of a chromosome. Each defective or deleted gene is 
responsible for the overall characteristics of the syndrome. Thus, the overall phenotype seen 
would depend on the number and function of the specific genes affected. 
 
Noonan syndrome, one of the most common multiple congenital anomaly syndromes, 
occurs in approximately one out of every 1000 to 2500 live births11. Noonan syndrome is also 
known as “Turner-like syndrome”, “male Turner syndrome”, “female pseudo-Turner 
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syndrome”, “Turner phenotype with normal karyotype”, “Bonnevie-Ullrich syndrome” and 
“pterygium colli syndrome”. 
Noonan syndrome was initially described in 1963 by Jacqueline Noonan12, a pediatric 
cardiologist. She had noticed that a number of her patients with cardiac anomalies (most 
commonly pulmonary stenosis and atrial and ventricular septal defects) were also of short 
stature and had atypical facies.  Characteristic facial features include a broad or webbed neck, 
low set and posteriorly angulated ears, ptosis, hypertelorism, and downward slanting eyes. 
These manifestations tend to become less pronounced with increasing age.  Since the initial 
discovery of this syndrome, a number of other associated features have been described (Table 
3)11.  
Similar to cherubism, Noonan syndrome is an autosomal dominantly inherited 
syndrome with variable expressivity.  Cases can also occur sporadically; presumably the result 
of a spontaneous mutation. Tartaglia et al13 reported that in slightly over 50% of 22 unrelated 
individuals tested, Noonan syndrome phenotype was associated with missense mutations in 
the gene PTPN11, which encodes the non-receptor tyrosine phosphatase protein SHP-2 
located on the long arm of chromosome 12. This protein is involved in a number of signal 
transduction pathways that regulate several developmental pathways, including cardiac 
semilunar valve development14. Recently, the same PTPN11 gene mutation was identified in 
two siblings in a family inheriting Noonan-like/ multiple giant cell lesions syndrome15. 
Diagnosis is usually based on clinical criteria. Since many affected individuals have 
mild manifestations, many cases go undiagnosed.  Prenatally, an association with fetal edema 
and cystic hygroma has been reported.  Molecular genetic testing of the PTPN11 gene is now 
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clinically available, with mutations being identified in about 50% of patients. PTPN11 genetic 
testing was not available when this patient was initially evaluated.  
Based on our patient’s clinical and radiographic presentation and histologic findings, our 
working diagnosis was that these giant cell lesions were a manifestation of Noonan syndrome. 
Molecular testing has been offered to the family, but to date they have opted not to undergo 
testing. 
 
Review of the Literature 
Cohen and Gorlin8 published the first review detailing the association of central giant 
cell granuloma-like lesions of the jaws with Noonan syndrome in 1991.  They reviewed 
previously published clinical and pathologic findings of 13 patients and included one patient 
that they had been following since 1974. Of the 14 total cases described, 7 also had 
polyarticular lesions of pigmented villonodular synovitis, which would place these cases under 
the spectrum of  “Noonan-like syndrome, cherubism, and polyarticular pigmented 
villonodular synovitis”. Cohen and Gorlin believed that both of these types of giant cell 
lesions have a common pathogenesis.  
To date, excluding the 7 cases described by Cohen and Gorlin that also presented with 
polyarticular pigmented villonodular synovitis, fewer than 15 cases of Noonan-like/multiple 
giant cell lesion syndrome have been reported in the English language literature (Table 4).  
 
Significance and Management 
There are a number of potentially significant medical concerns that clinicians should be 
aware of prior to performing any surgical procedure on a patient with suspected Noonan 
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syndrome (Table 5).  These risks include a high prevalence of congenital heart disease (as in 
our patient), bleeding diatheses (decreased coagulation factors XI and II, von Willebrand 
disease, thrombocytopenia, abnormal platelet function and stem cell dysfunction), an 
association with malignant hyperthermia and the potential of developing a life-threatening 
chylothorax. 
To rule out an occult bleeding diathesis, preliminary hematologic evaluation should 
include a complete blood count and differential, prothrombin time, partial thromboplastin 
time, and possibly measurement of factor XI levels. 
 
As the reported incidence of Noonan syndrome-associated giant cell lesions of the jaws 
is low, little is known of its natural history or what treatment approaches are most effective. 
Current treatment modalities have largely been extrapolated from published reports of the 
management of either conventional CGCGs of the jaws or cherubism. 
CGCGs of the jaws, especially smaller lesions, are commonly treated by surgical 
curettage. Aggressive lesions are occasionally treated by en bloc surgical resection. However, 
this approach can be disfiguring. Recent approaches for the treatment of large or multiple 
lesions have included weekly intralesional corticosteroid injection16,17, daily subcutaneous18 or 
intra-nasal19 administration of calcitonin and the use of interferon alpha-2a20.  The principal 
disadvantage to these approaches is the necessity of continuing treatment over a prolonged 
period of time. 
Based on the apparent clinical and histologic similarity between patients with Noonan 
syndrome-associated giant cell lesions of the jaws and cherubism, the few reported cases that 
describe the management of these lesions have based treatment on the assumption that their 
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behavior and clinical course is also similar. Consequently, management has generally 
involved long term follow-up, with the assumption that these lesions will stabilize or regress 
during puberty. Treatment is reserved for patients with functional or cosmetic impairment. 
Our plan is to follow this patient on a biannual basis. Presently, she has no functional or 
cosmetic impairment and is asymptomatic. 
 
Conclusion 
Even though our patient was eight years old at the time of presentation and had a history 
of pulmonary stenosis, her Noonan syndrome had gone undiagnosed until she presented with 
bilateral giant cell lesions of the mandible. This case underscores the importance of 
formulating a thorough differential diagnosis of giant cell lesions of the jaws. The histologic 
findings must be interpreted in light of the radiographic and clinical findings to arrive at a 
correct diagnosis.  
As in our patient, children with Noonan syndrome are predisposed to having a wide 
array of health problems (including congenital heart disease, bleeding diatheses, malignant 
hyperthermia, lymphangiomatosis), making it essential that all practitioners involved in caring 
for these patients be aware of their special needs prior to performing any surgical procedure.  




 Figure 1: Clinical Photograph. The patient’s ears were low set and small with 
thickened helices bilaterally. 
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Figure 2: Panoramic Radiograph. Note bilateral multilocular radiolucencies of the 
posterior mandible and anterior displacement of the prematurely developing mandibular third 
molar teeth. 
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Figure 3: Axial CT Scan. Note lack of significant cortical expansion. 
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Figure 4: High Power View of Histology. Numerous osteoclast-like giant cells in a background of 
spindle-shaped fibroblasts (Hematoxylin and eosin, original magnification 40x). 
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Table 1: Initial Clinical and Radiographic Differential Diagnosis 
 
 
•Multiple odontogenic keratocysts (e.g. associated with nevoid basal cell 
carcinoma syndrome) 
•Central giant cell granuloma (CGCG), bilateral 
•Cherubism 
•Syndromes associated with CGCGs (e.g. Noonan syndrome, neurofibromatosis 
type 1) 
•Multiple dentigerous cysts  
•Brown tumors of hyperparathyroidism  
•Langerhans’ cell histiocytosis 
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Table 2: Bilaterally Occurring Central Giant Cell 
Lesions Of The Jaws 
 
•Central giant cell granuloma, bilateral 
•“Brown tumor” of hyperparathyroidism 
•Cherubism 
•Noonan-like / multiple giant cell lesion syndrome  
•Noonan-like syndrome, cherubism, and polyarticular pigmented villonodular 
synovitis 
•Neurofibromatosis type 1 
•Ramon syndrome  (cherubism, gingival fibromatosis, epilepsy, mental 
deficiency, hypertrichosis, and stunted growth) 
 
Note: Histologically and radiographically, all of these conditions are essentially 
indistinguishable21. Clinical-radiological-pathologic correlation is required to 
arrive at the final diagnosis. 
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Table 3: Clinical Features of Noonan Syndrome 
 
 
•Congenital heart defects (pulmonary stenosis, hypertrophic cardiomyopathy, 
ASD, VSD) 
•Short stature 
•Broad or webbed neck 
•Low set, posteriorly angulated ears 
•Ptosis, hypertelorism, downward slanting eyes 
•Coarse +/- curly hair 
•Pectus excavatum (depressed sternum) 
•High arched palate 
•Cherubism-like multiple giant cell lesions 
•Cryptorchidism  
•Conductive hearing loss 
•Hypoplasia of lymphatics: potentially leading to chylothorax 
•Bleeding diatheses: decreased factors XI and II, von Willebrand disease, 
thrombocytopenia, abnormal platelet function22 
•Learning disabilities 
•Tendency to develop keloids following surgery 
•Association with multiple subcutaneous granular cell tumors23 
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Table 4: Published Reports of Noonan Syndrome/Central Giant Cell 
Granuloma-Like Lesions of the Jaws 
Authors Year Number of 
Patients 
Chuong et al24 1986 2 
Dunlap et al25 1989 4 
Cohen and Gorlin26 1991 1  
Levine et al27 1991 1 
Betts et al28 1993 1 
Addante and Breen29 1996 1 
Ucar et al30 1998 1 
Bertola et al31 2001 2 
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Table 5: Surgical Risks in Patients with Noonan Syndrome  
 
   
•Congenital heart disease 
•Bleeding diatheses. Presurgical hematology work-up recommended 
•Lymphangiomatosis of the pleura, lungs and chest wall; potentially leading to 
life-threatening chylothorax32 
•Association with malignant hyperthermia (King syndrome) 
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